Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ZIVO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Strome Investment Management LP | ZIVO Zivo Bioscience, Inc. | Buy | 100,000 | $2.00 | $200.0K Buy | Form 4 ↗ |
| Feb 27, 2026 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 1,543 | $9.72 | $15.0K Buy | Form 4 ↗ |
| Feb 12, 2026 | Strome Group, Inc. | ZIVO Zivo Bioscience, Inc. | Buy | 20,000 | $9.77 | $195.4K Buy | Form 4 ↗ |
| Feb 10, 2026 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 2,434 | $10.27 | $25.0K Buy | Form 4 ↗ |
| Jan 26, 2026 | Alison A. Cornell Director | ZIVO Zivo Bioscience, Inc. | Buy | 11,709 | $8.54 | $100.0K Buy | Form 4 ↗ |
| Jan 26, 2026 | John Bernard Payne President and CEO, Director | ZIVO Zivo Bioscience, Inc. | Buy | 11,709 | $8.54 | $100.0K Buy | Form 4 ↗ |
| Jan 14, 2026 | Christopher D. Maggiore Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 1,766 | $8.49 | $15.0K Buy | Form 4 ↗ |
| Jan 14, 2026 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 1,766 | $8.49 | $15.0K Buy | Form 4 ↗ |
| Nov 28, 2025 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 2,777 | $9.00 | $25.0K Buy | Form 4 ↗ |
| Oct 13, 2025 | Strome Investment Management LP | ZIVO Zivo Bioscience, Inc. | Buy | 20,259 | $12.34 | $250.0K Buy | Form 4 ↗ |
| Oct 10, 2025 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 1,659 | $12.05 | $20.0K Buy | Form 4 ↗ |
| Oct 8, 2025 | Christopher D. Maggiore Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 23,682 | $12.01 | $284.4K Buy | Form 4 ↗ |
| Sep 30, 2025 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 15,322 | $15.99 | $245.0K Buy | Form 4 ↗ |
| Jun 13, 2025 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 3,488 | $14.33 | $50.0K Buy | Form 4 ↗ |
| Apr 8, 2025 | Christopher D. Maggiore Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Sale | 20 | $16.25 | $325 Sale | Form 4 ↗ |
| Jan 22, 2025 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 2,880 | $17.53 | $50.5K Buy | Form 4 ↗ |
| Jan 22, 2025 | Laith L. Yaldoo Director, 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 7,200 | $17.53 | $126.2K Buy | Form 4 ↗ |
| Dec 26, 2024 | Mark E. Strome 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 75,000 | $20.19 | $1.5M Buy | Form 4 ↗ |
| Oct 16, 2024 | John Bernard Payne President and CEO, Director | ZIVO Zivo Bioscience, Inc. | Buy | 6,343 | $15.76 | $100.0K Buy | Form 4 ↗ |
| Oct 16, 2024 | Laith L. Yaldoo Director | ZIVO Zivo Bioscience, Inc. | Buy | 3,133 | $15.96 | $50.0K Buy | Form 4 ↗ |
| Aug 27, 2024 | Mark E. Strome 10% owner | ZIVO Zivo Bioscience, Inc. | Buy | 30,000 | $8.44 | $253.2K Buy | Form 4 ↗ |
21 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 8:53 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances